Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Gross Sales	$ 5,375,630	$ 6,240,526
Allowances	(225)	(155,308)
Total Net Sales	5,375,405	6,085,218
Cost of sales	1,817,907	2,517,452
Gross Profit	3,557,498	3,567,766
Operating expenses	4,623,333	7,613,947
Loss from operations	(1,065,835)	(4,046,181)
Decrease of contingent liability	69,752	61,000
Interest expense (income)	(418)	29,119
Loss before provision for income taxes	(996,501)	(3,956,062)
Benefit for income taxes	0	0
Net Loss	(996,501)	(3,956,062)
Preferred dividends	1,000,501	1,000,502
Net Loss attributable to cbdMD, Inc. common shareholders	$ (1,997,002)	$ (4,956,564)
Net Loss per share:
Basic and Diluted earnings per share (in dollars per share)	$ (0.67)	$ (3.7)
Weighted average number of shares Basic and Diluted: (in shares)	2,960,945	1,341,277